[Raynaud's Disease Treated with Captopril (Capoten). A Randomized Double-blind Cross-over Study]
Overview
Authors
Affiliations
Vasodilators for primary Raynaud's phenomenon.
Su K, Sharma M, Kim H, Kaganov E, Hughes I, Abdeen M Cochrane Database Syst Rev. 2021; 5:CD006687.
PMID: 33998674 PMC: 8127538. DOI: 10.1002/14651858.CD006687.pub4.
Oral vasodilators for primary Raynaud's phenomenon.
Stewart M, Morling J Cochrane Database Syst Rev. 2012; (7):CD006687.
PMID: 22786498 PMC: 6718219. DOI: 10.1002/14651858.CD006687.pub3.
Angiotensin converting enzyme inhibitors in Raynaud's phenomenon.
Challenor V Drugs. 1994; 48(6):864-7.
PMID: 7533694 DOI: 10.2165/00003495-199448060-00003.
Subjective and objective assessment of enalapril in primary Raynaud's phenomenon.
Challenor V, Waller D, Hayward R, Griffin M, Roath O Br J Clin Pharmacol. 1991; 31(4):477-80.
PMID: 2049258 PMC: 1368337. DOI: 10.1111/j.1365-2125.1991.tb05565.x.